Advances in graft-versus-host disease biology and therapy. - Wikidata - wikimedia - TriplyDB

Advances in graft-versus-host disease biology and therapy.

Advances in graft-versus-host disease biology and therapy.

http://www.wikidata.org/entity/Q34031916

about

The role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation The role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation Interaction between Mesenchymal Stem Cells and B-Cells The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies Innate lymphoid cells in graft-versus-host disease The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease Graft-versus-host disease: why have we not made more progress?Acute graft-versus-host disease: a bench-to-bedside update.T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 1.PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses CRK proteins selectively regulate T cell migration into inflamed tissues.Reveel: large-scale population genotyping using low-coverage sequencing data.Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.Kinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease.Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade Ezh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice.Modulation of oxidative phosphorylation and redox homeostasis in mitochondrial NDUFS4 deficiency via mesenchymal stem cells.TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host Disease IFN-γ mediates graft-versus-breast cancer effects via enhancing cytotoxic T lymphocyte activity.Extracellular adenosine-mediated modulation of regulatory T cells.Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects IL-17 genetic and immunophenotypic evaluation in chronic graft-versus-host disease.Dysfunction of bone marrow vascular niche in acute graft-versus-host disease after MHC-haploidentical bone marrow transplantation.Failure-free survival after initial systemic treatment of chronic graft-versus-host disease Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.Treatment of chronic graft-versus-host disease with bortezomib

P2860

Q24186279-8154D222-2949-423F-B7B8-9F2984F7253A Q24198004-C9EB9E93-778C-4FB5-8008-7C218A319975 Q26750859-BC88CEF7-F286-45EF-A507-A19ABDFDEB06 Q26751265-6343AAA6-7BB0-499D-B173-35B88C246753 Q26751959-29E6BC3B-5B9E-4FE4-8084-2C80D4FC8B77 Q26801315-5A38FFBF-6D14-4D90-A3A6-E5E54154A62D Q26824436-46989AEB-7B72-40D7-AB0F-0EDACFBA055B Q27008309-8F82B97D-6496-48D2-B5DC-D4C49FC6A031 Q27012940-B5C0752F-8AFF-4925-9A67-63BA0DBD21BD Q27687130-0D9820D4-E53E-4A62-9768-0BD30BE5812D Q28072227-7928FEDD-39B8-4618-A096-204B85B7AFC4 Q28072627-A7A11F3C-F6D7-4D1B-A2A8-79941F6CEE45 Q28076264-82583EF9-E23B-424F-9395-56DEED3AE362 Q28085397-C8F7EEA1-94D7-4380-94D8-F1A808F70E86 Q30253063-E21C9D44-CCBC-43F9-AC45-9E0AB9C63A04 Q30600094-B590421B-F29F-44C8-B7E4-6A5FDA72A900 Q30628412-A7F045CF-24D0-446D-A14E-55A93C8AB71C Q30992447-4623C391-8EDA-41E6-8203-EBE8089279C9 Q33411822-0600A1ED-0569-4C02-8411-88745C53E990 Q33618681-C60202F0-5B6E-4E93-9DD9-94D10F4E54B9 Q33619021-CB2BA1E9-BDDA-45FB-AB70-F604EC3A10AC Q33638762-1C274B40-63B6-41C1-B615-AD23D51AFAC8 Q33697267-1EA712B6-1D91-40E7-9C1C-C6EB4315738D Q33707337-FAD1189C-8422-48B9-A862-C34AF4EFBE3E Q33756801-D19E2CDC-3A17-4909-9B73-40C665A4CEFA Q33785788-FAE11686-F1DA-44E6-84AA-096734B55044 Q33792598-661C3773-AE5B-4054-BFD8-D1E616FA30D0 Q33804224-EAFF571D-1947-4EF3-8B33-5ABCCCA0E5C6 Q33809102-3D4D875B-2B42-421B-9D59-64227CC48A66 Q33824617-E5E53D74-584B-4D7F-96AD-BF0C99B4DF4C Q33830305-1910C9AE-A852-4013-9D98-6652B97EFC77 Q33835099-FD480E9B-86B7-4B29-BCF9-8ED541655BF5 Q33837471-397EF8E5-EFC8-407F-9B60-A748D15E670D Q33878542-E10B0CED-1D57-4CE4-A33C-C1AC4E3FE60F Q33905411-180743F6-4402-46AF-8841-80B723952498 Q34029809-88DC87C8-FC3A-46ED-B03C-2DBCD1D56F49 Q34041119-1BFA3784-E569-4095-BE2B-919C3F3E2490 Q34077787-5E262FB0-47BF-489D-8FCD-B4A229E36629 Q34109382-50146084-248C-49FF-9151-6834891685EB Q34137032-36C21953-9110-4C76-9EB3-2BFBA1FAAB54

P2860

Advances in graft-versus-host disease biology and therapy.

http://www.wikidata.org/entity/Q34031916

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Advances in graft-versus-host disease biology and therapy.

@ast

Advances in graft-versus-host disease biology and therapy.

@en

Advances in graft-versus-host disease biology and therapy.

@nl

type

label

Advances in graft-versus-host disease biology and therapy.

@ast

Advances in graft-versus-host disease biology and therapy.

@en

Advances in graft-versus-host disease biology and therapy.

@nl

prefLabel

Advances in graft-versus-host disease biology and therapy.

@ast

Advances in graft-versus-host disease biology and therapy.

@en

Advances in graft-versus-host disease biology and therapy.

@nl

P1433

Q34031916-B9EC3DB1-6791-44BC-90FE-6B33FA38D2EB

P1476

Q34031916-2C6EF411-A6A5-4B6A-8339-D60077E3EE73

P2093

Q34031916-2D54CF82-B4CD-4BF5-A7A2-4F7FA83F1AFB

Q34031916-5C5C5CD9-7079-4286-9E53-104A9EDCADC0

Q34031916-8006CAD4-9170-4723-92DA-873D439FF1A0

P2860

Q34031916-023BCB56-B29B-46B0-91CC-501EDFE44932

Q34031916-023D629A-7946-4A6C-88DB-1EF826EC88C0

Q34031916-03668EED-750F-47FC-BE40-5E3B3A4C9DA6

Q34031916-0714C09F-48D5-4525-917E-F86F02688097

Q34031916-0735100B-66E9-4CD5-B160-3C618F2A7D90

Q34031916-07C38626-AD87-4D4B-A97E-735578A8877B

Q34031916-0A0B9BCA-28DE-4D37-89F8-870AFC104955

Q34031916-125D6B24-73F2-4206-9BF2-2DCD3426C854

Q34031916-12D1575B-E4FF-4A91-B01C-407F38D0448A

Q34031916-13231853-1072-44FC-B381-5B2EF454CB75

P304

Q34031916-E0816013-7E02-408F-A4F3-1E01DACBA744

P31

Q34031916-40B3BE7E-8CDC-43B3-960F-DF9C4EADA728

P356

Q34031916-6A73DC05-FDCF-4FE4-8A0C-7BC5A8116235

P433

Q34031916-AAEE53EB-C401-4D4C-8293-D4FFF875A9AE

P478

Q34031916-31505A13-DBD0-41B5-8C44-22DEDF89B0B5

P577

Q34031916-6125A14C-9783-45FA-9769-1371877D9FE3

P5875

Q34031916-1C10201D-D97F-4551-ABF4-898C90763FA6

P698

Q34031916-5A69EF21-99A9-490D-890D-85227A215545

P932

Q34031916-2094756A-618D-4867-B688-29898CB76442

P356

P1433

Nature Reviews Immunology

P1476

Advances in graft-versus-host disease biology and therapy.

@en

P2093

Bruce R Blazar

http://www.w3.org/2001/XMLSchema#string

Mehrdad Abedi

http://www.w3.org/2001/XMLSchema#string

William J Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Human mesenchymal stem cells modulate allogeneic immune cell responses

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality

Regulation of the mevalonate pathway

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

Inducible apoptosis as a safety switch for adoptive cell therapy

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Leukocyte migration and graft-versus-host disease.

Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

P304

443-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRI3212

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224939505

http://www.w3.org/2001/XMLSchema#string

P698

22576252

http://www.w3.org/2001/XMLSchema#string

P932

3552454

http://www.w3.org/2001/XMLSchema#string